Passage Bio Inc [PASG] stock prices are up 20.90% to $0.4 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PASG shares have gain 19.56% over the last week, with a monthly amount drifted -11.38%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Rodman & Renshaw started tracking the stock with Buy rating on September 03, 2024, and set its price target to $7. On March 08, 2022, downgrade downgraded it’s rating to Neutral. Goldman downgraded its rating to a Neutral and decreased its price target to $6 on January 19, 2022. Raymond James initiated its recommendation with a Outperform and recommended $29 as its price target on July 01, 2021. BTIG Research started tracking with a Buy rating for this stock on June 15, 2021, and assigned it a price target of $25. In a note dated March 04, 2021, Goldman upgraded an Buy rating on this stock and boosted its target price from $28 to $30.
The stock price of Passage Bio Inc [PASG] has been fluctuating between $0.26 and $1.33 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Passage Bio Inc [NASDAQ: PASG] shares were valued at $0.4 at the most recent close of the market. An investor can expect a potential return of 1400.0% based on the average PASG price forecast.
Analyzing the PASG fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.74, Equity is -0.94 and Total Capital is -1.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.54.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3578 points at the first support level, and at 0.3152 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4302, and for the 2nd resistance point, it is at 0.4600.
Ratios To Look Out For
It’s worth pointing out that Passage Bio Inc [NASDAQ:PASG]’s Current Ratio is 3.74. In addition, the Quick Ratio stands at 3.74 and the Cash Ratio stands at 3.55.
Transactions by insiders
Recent insider trading involved ORBIMED ADVISORS LLC, 10% Owner, that happened on Jun 24 ’25 when 0.23 million shares were sold. 10% Owner, ORBIMED ADVISORS LLC completed a deal on Jun 26 ’25 to sell 0.21 million shares. Meanwhile, 10% Owner ORBIMED ADVISORS LLC sold 0.14 million shares on Jun 25 ’25.
